Epithelial cell cultures from normal glandular tissue of mice.

Transepithelial transport in cell culture. Proc Natl Acad Sci U S A (1976) 5.89

Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci U S A (1982) 2.44

Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44

Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol (1988) 2.26

Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol (1986) 2.16

Collagen reduces glycosaminoglycan degradation by cultured mammary epithelial cells: possible mechanism for basal lamina formation. Proc Natl Acad Sci U S A (1979) 2.05

Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels. Proc Natl Acad Sci U S A (1980) 1.65

Disruption of the keratin filament network during epithelial cell division. EMBO J (1982) 1.61

Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci U S A (1988) 1.57

Occluding junctions and cell behavior in primary cultures of normal and neoplastic mammary gland cells. J Cell Biol (1975) 1.57

Polyproteins related to the major core protein of mouse mammary tumor virus. J Virol (1978) 1.53

Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol (2000) 1.46

Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol Cell Biol (1993) 1.42

Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell (1995) 1.40

Type I collagen reduces the degradation of basal lamina proteoglycan by mammary epithelial cells. J Cell Biol (1981) 1.38

Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem (2010) 1.36

Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia (2002) 1.33

Inducers of mammalian cell differentiation stimulate dome formation in a differentiated kidney epithelial cell line (MDCK). Proc Natl Acad Sci U S A (1979) 1.32

New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line. Mol Cell Biol (1985) 1.26

Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol (2008) 1.14

Organization of cytokeratin bundles by desmosomes in rat mammary cells. J Cell Biol (1986) 1.10

The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements. Nucleic Acids Res (1990) 1.08

Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. J Virol (1983) 1.05

Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin. Proc Natl Acad Sci U S A (1980) 1.04

Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol (2008) 1.04

Establishment of two rabbit mammary epithelial cell lines with distinct oncogenic potential and differentiated phenotype after microinjection of transforming genes. Mol Cell Biol (1986) 1.00

CDP is a repressor of mouse mammary tumor virus expression in the mammary gland. J Virol (2000) 0.99

In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J Cell Biol (1998) 0.98

Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92

PI3K regulates branch initiation and extension of cultured mammary epithelia via Akt and Rac1 respectively. Dev Biol (2013) 0.90

Intestinal epithelial cells in vitro. Stem Cells Dev (2010) 0.89

Cell-specific proteins synthesized by Salmonella typhimurium. Infect Immun (1998) 0.89

Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion. J Cell Physiol (2015) 0.86

Identification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial Cells. PLoS One (2013) 0.86

Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep (2016) 0.85

Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J Virol (2012) 0.84

In vitro infectivity assay for mouse mammary tumor virus. Proc Natl Acad Sci U S A (1979) 0.84

Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure. Proc Natl Acad Sci U S A (2011) 0.84

Membrane 126-kilodalton phosphoglycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells. Proc Natl Acad Sci U S A (1983) 0.84

Highly sensitive detection of cancer cells using femtosecond dual-wavelength near-IR two-photon imaging. Biomed Opt Express (2012) 0.78

Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells. Int J Cancer (2016) 0.75

Premalignancy in vitro: progression of an initially benign epithelial cell line to malignancy. Br J Exp Pathol (1979) 0.75

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst (1995) 3.96

Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (1996) 3.54

Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst (1977) 3.35

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A (1992) 3.25

Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18

Induction of cell division in medium lacking serum growth factor by SV40. Virology (1971) 2.48

Growth of normal human mammary cells in culture. In Vitro (1980) 2.39

The Virulence of Biochemical Mutants of Klebsiella Pneumoniae. Proc Natl Acad Sci U S A (1952) 2.34

The separation of infectious and autointerfering particles in vesicular stomatitis virus preparations. Virology (1967) 2.25

Tissue culture studies of mouse mammary tumor cells and associated viruses. J Natl Cancer Inst (1972) 2.22

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res (1998) 1.88

Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst (1976) 1.86

Abortive infection of Escherichia coli strain W by T2 bacteriophage. J Mol Biol (1968) 1.84

Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res (1996) 1.77

Accumulation of a protein required for division during the cell cycle of Escherichia coli. J Bacteriol (1970) 1.71

Vesicular stomatitis virus RNA: complementarity between infected cell RNA and RNA's from infectious and autointerfering viral fractions. Biochem Biophys Res Commun (1968) 1.65

DNA amplification is rare in normal human cells. Proc Natl Acad Sci U S A (1990) 1.63

Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res (1996) 1.51

A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors. Mod Pathol (1991) 1.50

Source, alterations, characteristics and use of a new dog cell line (Cf2Th). In Vitro (1976) 1.49

Effect of prophage W on the propagation of bacteriophages T2 and T4. J Virol (1968) 1.46

A randomized double-blind study of the effect of distant healing in a population with advanced AIDS. Report of a small scale study. West J Med (1998) 1.43

Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care. Am J Hosp Palliat Care (2002) 1.41

Vesicular stomatitis virus maturation sites in six different host cells. J Gen Virol (1970) 1.41

Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Cancer Res (1989) 1.39

The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36

Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res (1991) 1.36

Production of fibronectin by human epithelial cells in culture. Cancer Res (1979) 1.34

Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am (1990) 1.33

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol (2001) 1.31

Replication initiates at a confined region during DNA amplification in Sciara DNA puff II/9A. Genes Dev (1993) 1.30

Clonal proliferation of cultured nonmalignant and malignant human breast epithelia. Cancer Res (1981) 1.29

The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat (2000) 1.27

Monoclonal marker that predicts early recurrence of breast cancer. Lancet (1987) 1.26

Effect of polycations on sensitivity of BALD-3T3 cells to murine leukemia and sarcoma virus infectivity. Appl Microbiol (1971) 1.26

Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue. J Natl Cancer Inst (1988) 1.26

Glandular epithelial cells from mice: a method for selective cultivation. J Natl Cancer Inst (1974) 1.25

Cell line derived from Balb-3T3 that is transformed by murine leukaemia virus: a focus assay for leukaemia virus. Nat New Biol (1972) 1.24

Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst (1977) 1.24

Effect of rifampicin and two of its derivatives on cells infected with Moloney sarcoma virus. Proc Natl Acad Sci U S A (1971) 1.22

The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Breast Cancer Res Treat (1998) 1.21

The biology of human cells in tissue culture. I. Characterization of cells derived from osteogenic sarcomas. Int J Cancer (1976) 1.20

Biological properties of human melanoma cells in culture. In Vitro (1979) 1.18

Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line. Proc Natl Acad Sci U S A (1972) 1.17

Origin recognition complex binding to a metazoan replication origin. Curr Biol (2001) 1.17

Cell dissociation techniques in human breast cancer--variations in tumor cell viability and DNA ploidy. Breast Cancer Res Treat (1989) 1.15

Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst (1992) 1.14

Infectivity and RNA patterns as functions of high- and low-dilution passage of murine sarcoma-leukemia virus: evidence for autointerference within an oncornavirus population. J Virol (1973) 1.13

Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res (1995) 1.12

Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res (1992) 1.11

The biology of breast cancer at the cellular level. Biochim Biophys Acta (1984) 1.11

Metabolism of benzo[a]pyrene by human mammary epithelial cells: toxicity and DNA adduct formation. Proc Natl Acad Sci U S A (1981) 1.11

Selective cell culture of primary breast carcinoma. Cancer Res (1995) 1.10

Selective cultivation of mammalian epithelial cells. Methods Cell Biol (1976) 1.09

Loss of heterozygosity on chromosome 1q in human breast cancer. Proc Natl Acad Sci U S A (1989) 1.09

Genetic analysis of simian virus 40. IV. Inhibited transformation of Balb-3T3 cells by a temperature-sensitive early mutant. J Virol (1972) 1.09

Immunobiology of heterotransplanted human tumors in nude mice. J Natl Cancer Inst (1977) 1.09

Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet (1992) 1.07

Immortalization in culture: occurrence at a late stage in the progression of breast cancer. J Natl Cancer Inst (1987) 1.07

Detection and quantitation of simian virus 40 genetic material in abortively transformed BALB-3T3 clones (mice-diploid cells-virus equivalents). Proc Natl Acad Sci U S A (1972) 1.06

Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res (1994) 1.06

Fibronectin production by human mammary cells. J Natl Cancer Inst (1981) 1.05

The assessment of physiological changes occurring during rehabilitation of lower limb injuries at the Joint Services Medical Rehabilitation Unit. Proc R Soc Med (1974) 1.05

Monoclonal antibody that defines human myoepithelium. Proc Natl Acad Sci U S A (1985) 1.05

Tumor-specific cell-mediated immunity in household contacts of cancer patients.. J Clin Invest (1975) 1.04

Abortive infection of Shigella dysenteriae P2 by T2 bacteriophage. J Virol (1969) 1.03

Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation (1986) 1.03

Motor neurone disease presenting as respiratory failure. Br Med J (Clin Res Ed) (1986) 1.03

Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res (1994) 1.01

Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells. Cancer Res (1997) 1.00

Electron microscopic study of the morphogenesis of vesicular stomatitis virus. J Virol (1968) 0.98

Effect of passage in culture on a clone of BALB/c 3T3 cells transformed by simian virus 40. J Virol (1976) 0.97

Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. J Clin Invest (1975) 0.97

Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator. Am J Physiol (1999) 0.96

Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice. J Natl Cancer Inst (1980) 0.96

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer. Br J Cancer (1995) 0.96

Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue. Breast Cancer Res Treat (1991) 0.95

Reproductive performance of totally confined sheep bred with semen extended in a lactose-egg yolk-glycerol buffer and stored at 5 degrees C. Can J Comp Med (1982) 0.95

Morphological and biophysical properties of the Mason-Pfizer monkey virus. J Natl Cancer Inst (1972) 0.95

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer (1995) 0.94

Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma. Cancer Res (1975) 0.93

Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene (1990) 0.93

Inhibition of MSV viral function by rifampicin derivatives. Medicine (Baltimore) (1972) 0.91

Use of an efficient method for culturing human mammary epithelial cells to study adriamycin sensitivity. Cancer Chemother Pharmacol (1981) 0.91

Biological properties of a syncytia-forming agent isolated from domestic cats (feline syncytia-forming virus). Proc Soc Exp Biol Med (1970) 0.91